Lightbox
Bronze Award
A New Way to Wegovy
Novo Nordisk
United States
2026
Share:
Facebook Linkedin X WhatsApp

Case Image / Board
Case Study Video
Execution Video

To see entry media, create an account or log in.
Logging in grants access to Advanced Search
and more Entry Details.

Entrant Company
M+C Saatchi North America
Entry Type
Direct-to-Consumer: Branded
Launch Country
United States
Program
Clio Health 2026
Program
Traditional Mediums
Advertiser Category
Pharmaceutical
Medium
Film
Category
61 Seconds to Five Minutes
Wegovy was launching the first FDA-approved weight-loss GLP-1 pill during the Super Bowl. But there was a problem: cultural stigma said taking prescription weight-loss medication was "cheating." So we changed the conversation using humor, while still responsibly educating viewers on the considerations and safety profile of Wegovy. Our spot exposed a simple contradiction: people would gladly take a pill for anything else—parallel parking, flying, rescuing a cat—but judge weight-loss medicine. The repeatable hook "If there was a pill for ___, I'd take it" paired with an all-star comedy ensemble made the message memorable. Results: 1.5 billion impressions, 20x search spike, and Wegovy became the #1 searched branded GLP-1.
Credits

To see entry credits, create an account or log in.
Logging in grants access to Advanced Search and more Entry Details.

Duplicate statues available now
Buy a Statue in Film to Celebrate Your Team

Ads of the World